IRF5 and psoriasis: Interferon signalling has long been implicated in psoriasis pathogenesis; Dand et al. found IRF1 and IRF5 to be predicted by TWAS to be upregulated in the presence of a known psoriasis risk variant associated with IRF1 and a novel risk variant identified through the accompanying GWAS, associated with IRF5 [32].